Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Hindalco 148.45 0.27
Bhel 242.00 1.89
Ong Corp 400.05 1.97
Tata Stl 457.10 0.29
Tata Mot 519.45 3.54
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Panacea Biotec Limited
Panacea Biotec Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:531349NSE:PANACEABIOBloomberg:PNCB@INReuters:PNCA.BO
Market Lot: 1Face Value: 1ISIN Demat: INE922B01023
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
19-SEP-13 Panacea Biotec, today announced that World Health Organization (WHO) has completed the evaluation process of pre-qualification (PQ) of its Pentavalent vaccine EasyfiveTT (DTP-HepB-Hib) and WHO has informed that they are initiating the arrangements for PQ. 07-JAN-13 Panacea Biotec has announced that the company has opened up its wholly owned subsidiary in UAE in the name of Panol Industries RMC FZE. 17-DEC-12 Panacea Biotec, India`s...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Panacea Bio sets up subsidiary in UAE  -IRIS 07-Jan-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1315.004671.405304.20
Other Income3.10116.4054.30
Total Income1318.104787.805358.50
Cost of goods sold1199.305975.206604.80
OPBDIT118.80-1187.40-1246.30
PAT-235.40-4.20-2301.30
Gross Block---
Equity capital61.3061.3061.30
EPS (Rs.)--0.07-37.57
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI) 9.0-24.8-23.3
Net margin (% of OI)-17.9-0.1-42.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Ambala - Chandigarh Highway
Lalru
Punjab-140 501
PHONE
(01762) 505 90
FAX
(01762) 5059 06/ 09
 
Board of Directors
Board Meetings
Date Purpose
31-OCT-14 Quarterly Results
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer